Evidence map›Paper›PMID 37272687›Full record

ArticleEMBO reports2023

Arms race between anti-silencing and RdDM in noncoding regions of transposable elements.

Taku Sasaki, Kae Kato, Aoi Hosaka, Yu Fu, Atsushi Toyoda, Asao Fujiyama, Yoshiaki Tarutani, Tetsuji Kakutani

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Comparative Analysis of Active LTR Retrotransposons in Sunflower (International journal of molecular sciences · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Taku SasakiThe University of Tokyo, Tokyo, Japan.ORCID 0000-0002-3729-399X
Kae KatoNational Institute of Genetics, Mishima, Japan.
Aoi HosakaNational Institute of Genetics, Mishima, Japan.ORCID 0000-0003-0494-3359
Yu FuNational Institute of Genetics, Mishima, Japan.
Atsushi ToyodaNational Institute of Genetics, Mishima, Japan.ORCID 0000-0002-0728-7548
Asao FujiyamaNational Institute of Genetics, Mishima, Japan.
Yoshiaki TarutaniNational Institute of Genetics, Mishima, Japan.
Tetsuji KakutaniThe University of Tokyo, Tokyo, Japan.ORCID 0000-0002-6137-4474
National Institute of Genetics · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transposable elements (TEs) are among the most dynamic parts of genomes. Since TEs are potentially deleterious, eukaryotes silence them through epigenetic mechanisms such as repressive histone modifications and DNA methylation. We previously reported that Arabidopsis TEs, called VANDALs, counteract epigenetic silencing through a group of sequence-specific anti-silencing proteins, VANCs. VANC proteins bind to noncoding regions of specific VANDAL copies and induce loss of silent chromatin marks. The VANC-target regions form tandem repeats, which diverge rapidly. Sequence-specific anti-silencing allows these TEs to proliferate with minimum host damage. Here, we show that RNA-directed DNA methylation (RdDM) efficiently targets noncoding regions of VANDAL TEs to silence them de novo. Thus, escape from RdDM could be a primary event leading to the rapid evolution and diversification of sequence-specific anti-silencing systems. We propose that this selfish behavior of TEs paradoxically could make them diverse and less harmful to the host.

Indexed as

ArabidopsisArabidopsis ProteinsDNA MethylationDNA Transposable ElementsEpigenesis, GeneticGene Expression Regulation, PlantGene SilencingArabidopsis ProteinsDNA Transposable Elementsanti-silencingDNA methylationRdDMtransposable elements

Identifiers

PMID37272687
PMCPMC10398659
OpenAlexW4379376261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.